- NASP Submits Comments on CY 2027 Home Health and DMEPOS Policies Sep 01 NASP submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the CY 2027... read more
- NASP Submits Comments on CMS’ Proposed 340B Payment Changes Sep 01 NASP submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the CY 2027... read more
- New Issue of Specialty Rx Advisor from Cold Chain Technologies Aug 13 The next issue of the Specialty Rx Advisor is available! This quarterly newsletter is a resource... read more
- Read the Latest Issue of The Advocate! Jun 11 This issue highlights notable news and happenings across the industry and our organization. Click here to... read more
- New Distinction in Immunoglobulin Therapy Recognition from ACHC Apr 14 ACHC is pleased to introduce the Distinction in Immunoglobulin Therapy, a new recognition for pharmacies that... read more
- New Issue of Specialty Rx Advisor, from Cold Chain Technologies – Quarter 1, 2026 Mar 30 The next issue of the Specialty Rx Advisor is available! This quarterly newsletter is a resource... read more
- NASP Submits Comments on Producer Responsibility Packaging and Paper Products Regulations Mar 05 NASP submitted comments on the proposed COMAR 26.04.14 – Packaging and Paper Products – Producer Responsibility.... read more
- Corporate Member Spotlight: Claritas Rx Mar 02 NASP is pleased to shine the Spotlight on Claritas Rx, a corporate member of the month.... read more
- NASP Submits Comments on Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model Feb 26 In comments on CMS’s proposed GUARD Model for Medicare Part D, NASP cautioned that the international... read more
- NASP Submits Comments on Proposed Regulations for Global Benchmark for Efficient Drug Pricing (GLOBE) Model; Proposed Rule (90 FR 60244) Feb 26 In comments on CMS’s proposed Global Benchmark for Efficient Drug Pricing (GLOBE) Model, NASP urged revisions... read more